Press release
Global Pharmaceutical Contract Development and Manufacturing Market to Reach $261.57 Billion by 2031, Driven by Advancements in Biologics and Generic Drug Demand
[Redding, California] - Meticulous Research®, a leading global market research firm, has unveiled its latest comprehensive analysis titled "Pharmaceutical Contract Development &Manufacturing Market Size, Share, Forecast, & Trends Analysis by Service
(Manufacturing [API, FDF {Parenteral, Injectable, Tablet, Capsule, Oral Liquid, Biologics}], Drug Development) End User - Global Forecast to 2031."
Download Sample Report Here : https://www.meticulousresearch.com/download-samplereport/cp_id=5171
According to the report, the pharmaceutical contract development and manufacturing market is poised to reach a significant milestone of $261.57 billion by 2031, registering a compound annual growth rate (CAGR) of 7.4% from 2024 to 2031.
1 Market Growth Catalysts
The growth trajectory of the pharmaceutical contract development and manufacturing market is primarily fueled by the pharmaceutical industry's increasing complexity, alongside a growing reliance on cutting-edge manufacturing technologies. The surge in pharmaceutical R&D investments, the expiration of critical patents, and the escalating demand for generic medicines and biologics are additional key drivers. However, challenges such as supply chain disruptions and stringent regulatory frameworks are creating headwinds for the market.
2 Emerging Opportunities and Challenges
As the market evolves, it presents notable opportunities, particularly in the burgeoning sectors of cell therapies, gene therapies, and personalized medicine. The growth in high-potency active pharmaceutical ingredients (HPAPI) and antibody-drug conjugates (ADC) markets further underscores the potential for expansion. However, the market also faces significant challenges, including intellectual property risks and a shortage of skilled professionals required to navigate the complexities of pharmaceutical manufacturing.
To gain more insights into the market with a detailed table of content and figures, click here: https://www.meticulousresearch.com/product/pharmaceutical-contract-development-and-manufacturing-market-5171
3 Key Industry Players
The pharmaceutical contract development and manufacturing landscape is dominated by several key players, including:
• Lonza Group Ltd. (Switzerland)
• Catalent Inc. (U.S.)
• Patheon (a subsidiary of Thermo Fisher Scientific Inc., U.S.)
• Recipharm AB (Sweden)
• C.H. Boehringer Sohn AG & CO. KG. (Germany)
• Aurobindo Pharma Ltd. (India)
• Jubilant Pharmova Limited (India)
• Fareva SA (Luxembourg)
• Vetter Pharma International GmbH (Germany)
• Aenova Group (Germany)
• WuXi Biologics Inc. (China)
• Piramal Enterprises Limited (India)
• Almac Group (U.K.)
• Fabbrica Italiana Sintetici S.p.A. (F.I.S., Italy)
• Samsung Biologics Co., Ltd. (South Korea)
• Cambrex Corporation (U.S.)
• Siegfried Holdings AG (Switzerland)
• FUJIFILM Diosynth Biotechnologies (Japan)
• Curia Global, Inc. (U.S.)
Quick Buy: https://www.meticulousresearch.com/Checkout/67156803
4 Market Segmentation and Future Outlook
The report categorizes the pharmaceutical contract development and manufacturing market by type, end user, and geography. Notably, the biologics manufacturing services segment is expected to experience a higher CAGR of 11.1% during the forecast period. This segment is further subdivided into finished dosage form (FDF) manufacturing services and active pharmaceutical ingredient (API) manufacturing services. The FDF category, driven by the rising importance of biologics and their intricate manufacturing processes, is anticipated to lead the growth.
Among end users, large pharmaceutical companies are projected to dominate the market, accounting for 42.3% of the market share by 2024. The increasing complexity of drug research and the high costs associated with facility maintenance have made contract manufacturers indispensable to large biotech and pharmaceutical companies. Additionally, with the expiration of many drug patents, these companies increasingly rely on contract development firms to bring generic versions of their drugs to market.
5 Regional Insights
Geographically, North America is poised to maintain its leadership in the pharmaceutical contract development and manufacturing market, with an estimated 44.3% market share by 2024. This dominance is supported by a diversified product pipeline, emerging therapies, shifting customer demands, and an increasing focus on biologics and generic drugs. North America also benefits from a large production base for APIs, advanced manufacturing capabilities, and the presence of major pharmaceutical companies.
Request Sample Report Here: https://www.meticulousresearch.com/request-samplereport/cp_id=5171
Key Questions Addressed in the Report
• What are the high-growth market segments by type, end user, and region/country?
• What are the historical market sizes and forecasts for 2024-2031?
• What are the primary drivers, restraints, opportunities, and challenges in the market?
• Who are the major players and market leaders?
• What recent developments and strategies have shaped the competitive landscape?
• Which regions/countries are experiencing the highest growth?
Contact Information
Meticulous Research®
Email: sales@meticulousresearch.com
Phone: +1-646-781-8004
LinkedIn: Connect with us on LinkedIn
Mr. Khushal Bombe
Meticulous Market Research Inc.
1267 Willis St, Ste 200 Redding,
California, 96001, U.S.
USA: +1-646-781-8004
Europe : +44-203-868-8738
APAC: +91 744-7780008
Email- sales@meticulousresearch.com
Meticulous Research® was founded in 2010 and incorporated as Meticulous Market Research Pvt. Ltd. in 2013 as a private limited company under the Companies Act, 1956. Since its incorporation, the company has become the leading provider of premium market intelligence in North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Global Pharmaceutical Contract Development and Manufacturing Market to Reach $261.57 Billion by 2031, Driven by Advancements in Biologics and Generic Drug Demand here
News-ID: 3637518 • Views: …
More Releases from Meticulous Research®
Direct Air Capture Market: Transforming Carbon Removal for a Net-Zero Future
Introduction
The global Direct Air Capture (DAC) market has entered a period of rapid transformation as nations, industries, and corporations intensify their efforts to achieve net-zero emissions. Valued at $136.5 million in 2024, the market is projected to grow significantly, reaching approximately $6.93 billion by 2035. This expansion, driven by a remarkable compound annual growth rate (CAGR) of 43.3% between 2025 and 2035, highlights the growing importance of DAC technologies in…
European Direct-to-Consumer Genetic Testing Market Outlook 2025-2035
Introduction
The European direct-to-consumer (DTC) genetic testing market is expanding at a remarkable pace, reflecting rising consumer interest in personalized healthcare and genetic insights. Valued at $464 million in 2025, the market is projected to grow at a compound annual growth rate (CAGR) of 23.3%, reaching nearly $3.78 billion by 2035. This growth underscores how advances in genomic sequencing, combined with increasing health awareness, are reshaping the healthcare and wellness landscape…
Peer-to-Peer Energy Trading Platforms Market Outlook 2025-2035
Introduction
The global peer-to-peer (P2P) energy trading platforms market is undergoing rapid transformation as new technologies reshape how energy is generated, distributed, and traded. Valued at $138 million in 2024, the market is projected to grow significantly, reaching nearly $2.34 billion by 2035. This growth, at a compound annual growth rate (CAGR) of 29.7% from 2025 to 2035, highlights the increasing adoption of decentralized energy solutions and digital platforms that empower…
Dermoscopy and Skin Visualization Devices Market Outlook to 2035
Introduction
The global dermoscopy and skin visualization devices market is entering a phase of rapid transformation, driven by the increasing need for early detection of skin conditions and the rising incidence of skin cancer worldwide. Valued at $1.33 billion in 2024, the market is expected to reach nearly $3.3 billion by 2035, expanding from an estimated $1.43 billion in 2025 at a compound annual growth rate (CAGR) of 8.7% during the…
More Releases for API
Api 607 Vs API 608: A Comprehensive Comparison Guide Of Industrial Valve
Introduction: Why are API standards so important for industrial valves?
In high-risk industries such as oil and gas, chemicals and power, the safety and reliability of valves can directly affect the stability of production systems. The standards set by API (American Petroleum Institute) are the technical bible of industrial valves around the world. Among them, API 607 and API 608 are key specifications frequently cited by engineers and buyers.
This article will…
Vehicle API Market 2023 | Futuristic Technology- CarAPI, Caruso, One Auto API, A …
The Vehicle API market research report delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. The Vehicle API report also incorporates the current and future global market outlook in the emerging and developed markets. Moreover, the report also investigates regions/countries expected to witness the fastest growth rates during the forecast period.
The Vehicle API research report also provides insights of different regions that are…
Face Recognition API Market Growth, Business Overview 2023, and Forecast to 2030 …
Facial recognition is a way of recognizing a human face through technology. A facial detection system uses biometrics to map facial features from a photograph or video. It compares information with a database of known faces to find a match. Moreover, the accuracy of facial recognition systems has improved way better in the last decade. Recent market developments and competitive strategies such as expansion, product launch, and development, partnership, merger,…
API Management Market Report 2018: Segmentation by Solution (API Portal, API Gat …
Global API Management market research report provides company profile for Akana, Inc. (U.S.), Apiary, Inc. (U.S.), Axway, Inc. (France), CA Technologies, Inc. (U.S.), Cloud Elements, Inc. (U.S.), Dell Boomi, Inc. (U.S.), DigitalML (U.S.), Fiorano Software, Inc. (U.S.), Google, Inc. (U.S.), Hewlett-Packard Enterprises Co. (U.S.), IBM Corporation (U.S.), Mashape Inc. (U.S.) and Others.
This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical…
Telecom API Market: OTT Service Providers Continue Cutting into Telecom API Prof …
The highly fragmented market of telecom API holds a staggering number of service providers and aggregators that are already offering their APIs to various telecom carriers. Alcatel Lucent, Apigee Corp., and Fortumo OU were the leading providers of telecom API from a global perspective in 2014. Telecom carriers have partnered with them and other prominent players in the past to launch APIs in the market.
According to Transparency Market Research’s latest…
Small Molecule API Market Growth Drivers 2018 | by Types Synthetic/Chemical API, …
Complete Study of Small Molecule API Market Research Report is added on MarketResearchFuture.com with Latest Advancement. Detail analysis on possible segments and sub segments of the Small Molecule API Market. Along with this regional analysis of the market which includes North America, Europe, Asia Pacific and Middle East and Africa.
Global Small Molecule API Market – Overview
Development in the small molecule API can be attributed due to the growth observed in…
